These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 37794630)
1. Analysis of total antibody levels in university hospitals health workers vaccinated against COVID-19 in Abidjan (Côte d'Ivoire). Romualde DS; Liliane SK; Honoré AA; Koffi N; Jocelyne SY; Richard YO; Patricia-Victorine KA; Aniela AAU; Roselle MLC; Salimata M; Doris O Egypt J Immunol; 2023 Oct; 30(4):77-85. PubMed ID: 37794630 [TBL] [Abstract][Full Text] [Related]
2. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine. Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR Front Immunol; 2022; 13():827306. PubMed ID: 35173736 [TBL] [Abstract][Full Text] [Related]
3. [Factors Affecting Side Effects, Seroconversion Rates and Antibody Response After Inactivated SARS-CoV-2 Vaccination in Healthcare Workers]. Şenol Akar Ş; Akçalı S; Özkaya Y; Gezginci FM; Cengiz Özyurt B; Deniz G; Karadağ Yalçın F; Özer D; Dündar Erbay P; Eser E Mikrobiyol Bul; 2021 Oct; 55(4):519-538. PubMed ID: 34666653 [TBL] [Abstract][Full Text] [Related]
4. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19? Scaggs Huang F J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545 [TBL] [Abstract][Full Text] [Related]
5. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine]. Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239 [TBL] [Abstract][Full Text] [Related]
6. [Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level]. Ayhancı T; Toptan H; Özer YE; Uzar S; Enül H; Adıay C; Sarac F; Dheir H; Köroğlu M; Hasöksüz M; Altındiş M Mikrobiyol Bul; 2022 Jul; 56(3):416-431. PubMed ID: 35960235 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco). Ben Houmich T; Tali A; Debbagh F; Lamrani Hanchi A; Soraa N Int J Immunopathol Pharmacol; 2022; 36():3946320221133697. PubMed ID: 36215392 [TBL] [Abstract][Full Text] [Related]
9. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.]. Casas Fischer R Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347 [TBL] [Abstract][Full Text] [Related]
10. Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic. Brehm TT; Thompson M; Ullrich F; Schwinge D; Addo MM; Spier A; Knobloch JK; Aepfelbacher M; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J Int J Hyg Environ Health; 2021 Sep; 238():113851. PubMed ID: 34601375 [TBL] [Abstract][Full Text] [Related]
11. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675 [TBL] [Abstract][Full Text] [Related]
12. Subregional origins of emerging SARS-CoV-2 variants during the second pandemic wave in Côte d'Ivoire. Anoh EA; Wayoro O; Monemo P; Belarbi E; Sachse A; Wilkinson E; San JE; Leendertz FH; Diané B; Calvignac-Spencer S; Akoua-Koffi C; Schubert G Virus Genes; 2023 Jun; 59(3):370-376. PubMed ID: 36932280 [TBL] [Abstract][Full Text] [Related]
13. Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study. Reusch J; Wagenhäuser I; Gabel A; Eggestein A; Höhn A; Lâm TT; Frey A; Schubert-Unkmeir A; Dölken L; Frantz S; Kurzai O; Vogel U; Krone M; Petri N J Med Virol; 2023 Jan; 95(1):e28300. PubMed ID: 36369641 [TBL] [Abstract][Full Text] [Related]
14. IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers. Decru B; Van Elslande J; Steels S; Van Pottelbergh G; Godderis L; Van Holm B; Bossuyt X; Van Weyenbergh J; Maes P; Vermeersch P Front Immunol; 2022; 13():909910. PubMed ID: 35784321 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine. Kobashi Y; Shimazu Y; Kawamura T; Nishikawa Y; Omata F; Kaneko Y; Kodama T; Tsubokura M PLoS One; 2022; 17(6):e0269917. PubMed ID: 35687563 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 anti immunoglobulin G antibodies serum levels among health care workers post COVID -19 vaccination: A single center study. Saad SS; Omar WH; Attia FM; El Sayed AE; Eida MM; Nemr NA Egypt J Immunol; 2023 Oct; 30(4):30-39. PubMed ID: 37787771 [TBL] [Abstract][Full Text] [Related]
17. [Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?]. Kara E; Tanır F; Demirhindi H; Mete B; Kibar F; Çetiner S; Candevir A; İnaltekin A Mikrobiyol Bul; 2022 Jul; 56(3):566-573. PubMed ID: 35960246 [TBL] [Abstract][Full Text] [Related]
18. Transition of Antibody Titers after SARS-CoV-2 mRNA Vaccination in Japanese Healthcare Workers. Kitabatake M; Ouji-Sageshima N; Sonobe S; Furukawa R; Konda M; Hara A; Aoki H; Suzuki Y; Imakita N; Nakano A; Fujita Y; Shichino S; Nakano R; Ueha S; Kasahara K; Muro S; Yano H; Matsushima K; Ito T Jpn J Infect Dis; 2023 Jan; 76(1):72-76. PubMed ID: 36047181 [TBL] [Abstract][Full Text] [Related]
19. Assessment of handwashing impact on detection of SARS-CoV-2, Staphylococcus aureus, Escherichia coli on hands in rural and urban settings of Côte d'Ivoire during COVID-19 pandemic. Traoré SG; Fokou G; Wognin AS; Dié SAG; Amanzou NAA; Heitz-Tokpa K; Tetchi SM; Seko MO; Sanhoun AR; Traoré A; Anoh EA; Tiembre I; Koussemon-Camara M; Akoua-Koffi C; Bonfoh B BMC Public Health; 2024 May; 24(1):1380. PubMed ID: 38778328 [TBL] [Abstract][Full Text] [Related]
20. Antibody Responses to the BNT162b2 mRNA Vaccine in Healthcare Workers in a General Hospital in Japan: A Comparison of Two Assays for Anti-spike Protein Immunoglobulin G. Hibino M; Watanabe S; Kamada R; Tobe S; Maeda K; Horiuchi S; Kondo T Intern Med; 2022 Mar; 61(6):811-819. PubMed ID: 34980798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]